美国食品和药物管理局禁止使用7-OH kratom 化合物, 理由是类似阿片类药物的风险和滥用潜力. FDA moves to ban 7-OH kratom compound, citing opioid-like risks and potential for abuse.

林业发展局正努力禁止含有7-羟丁二烯(7-OH)的产品,这是一种源于Kratom的强效化合物,因为它具有类阿片类效应,而且有可能被滥用。 The FDA is pushing to ban products containing 7-hydroxymitragynine (7-OH), a potent compound derived from kratom, due to its opioid-like effects and potential for abuse. 7-OH在加油站和便利商店销售的无管制产品中被发现,其威力高达吗啡的13倍。 Found in unregulated products sold at gas stations and convenience stores, 7-OH is up to 13 times more potent than morphine. 林业发展局已向7家公司发出警告信,并在决定将7-OH类药物与海洛因和迷幻剂等物质一起列为表一药物之前征求公众意见,以防止阿片成瘾的新浪潮。 The FDA has sent warning letters to seven companies and is seeking public comment before deciding to classify 7-OH as a Schedule I drug, alongside substances like heroin and LSD, to prevent a new wave of opioid addiction.